Other therapies were linked to increased adverse events such as stroke [11], hyperkalemia [13,15], hypotension [13], acute kidney injury (AKI) [15], and major adverse cardiovascular events (MACE) [14]
[2] [4] Regular monitoring and open communication with your healthcare team are essential for optimising the benefits of GLP-1 therapy whilst minimising adverse effects
The decision meant that members using semaglutide for weight loss through brand names like Wegovy, or tirzepatide through Zepbound , would need to either find alternative funding or discontinue their protocols entirely
Clinical Studies and Results Clinical trials have consistently shown the efficacy of GLP-1 agonists for weight loss
We next assessed mitochondrial metabolism of glucose and palmitic acid by measuring the oxygen consumption rate (OCR)
GLP-1 medications are typically administered via subcutaneous injection, either daily or weekly depending on the specific formulation
